Literature DB >> 31872806

Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis.

Lujain F Bashamakh1, Shouq M Alsharif, Lamis A Wayyani, Alaa E Alghamdi, Ghaida M Fatani, Hind A Alnajashi, Foziah J Alshamrani.   

Abstract

OBJECTIVE: To assess the awareness of patients with multiple sclerosis about the relationship between smoking and multiple sclerosis in Saudi Arabia.
METHODS: A descriptive cross-sectional study was carried out in 2018 for 162 patients who are attending a tertiary hospital in Jeddah, Kingdom of Saudi Arabia. Self-administered questionnaire and telephone-based interview were used to collect the data. The Analysis was carried out through a statistical package for the social sciences (SPSS) software version 21 by using chi-square.
RESULTS: A total of 162 patients responded to the questionnaire (response rate, 58.1%). Among the respondents, 56 were current smokers, and 41 of them were males. Thirty-nine patients had a previous cessation attempt, and in 64.1% of the cases, it was mainly a self-made decision. Doctors counseled only 52.7% of the active smokers regarding the effect of smoking on the progression of their disease.
CONCLUSION: Results indicate that there a is low level of awareness regarding the risk of smoking on multiple sclerosis. Therefore, educational programs and campaigns would be beneficial to fulfill the gap. Moreover, Health institutions and health care workers should take this issue into account when counseling the patient.

Entities:  

Mesh:

Year:  2019        PMID: 31872806     DOI: 10.17712/nsj.2019.4.20190027

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  1 in total

1.  Smoking habits, awareness and support needs for cessation among people with multiple sclerosis in Australia: findings from an online survey.

Authors:  Isabelle Weld-Blundell; Lisa Grech; Ron Borland; Sarah L White; Roshan das Nair; Claudia H Marck
Journal:  BMJ Open       Date:  2022-07-29       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.